Willkie advised Insight Partners on the deal, while Kirkland & Ellis advised TA Associates and Aptean, and Vista. Insight Partners announced the acquisition of a minority stake in...
Insight Partners’ Acquisition of a Minority Stake in Aptean
Levine Leichtman Capital Partners’s Acquisition of AGDATA
Honigman advised LLCP, while Kirkland & Ellis advised Vista Equity Partners and its portfolio company AGDATA on the deal. Levine Leichtman Capital Partners (“LLCP”), a Los...
Francisco Partners’ Acquisition of bswift
Kirkland & Ellis advised Francisco Partners in the transaction, while Fried, Frank, Harris, Shriver & Jacobson and Dechert advised CVS Health. Francisco Partners, a leading global...
Goldman Sachs Petershill and Hunter Point Capital’s Investment in SLR Capital Partners
Kirkland & Ellis advised SLR, while Fried, Frank, Harris, Shriver & Jacobson advised Petershill and HPC on the deal. SLR Capital Partners, LLC (“SLR”), a boutique...
VSP Vision’s Acquisition of Professional Eye Care Associates of America
Kirkland & Ellis advised VSP Vision, while Locke Lord advised PECAA and Nautic Partners on the deal. VSP Vision, the first and only national not-for-profit vision...
Pathfinder Acquisition Corporation’s Business Combination with Movella
Kirkland & Ellis advised Pathfinder Acquisition Corporation on the deal, Pillsbury Winthrop Shaw Pittman advised Movella, Latham & Watkins advised Francisco Partners. Pathfinder Acquisition Corporation (NASDAQ:...
Vital Records Control’s Acquisition of 2-20 Records Management
Kirkland & Ellis advised Windjammer Capital Investors and its portfolio company, Vital Records Control, on the deal. Vital Records Control (VRC) announced its acquisition of 2-20 Records...
Platinum Equity’s Acquisition of a Controlling Stake in Hop Lun
Mayer Brown advised Hop Lun, while Latham & Watkins provided legal counsel and Kirkland & Ellis provided debt financing counsel to Platinum Equity on the transaction....
Aspire Pharma’s Acquisition of Morningside Pharmaceuticals
Kirkland & Ellis advised H.I.G. Capital and its portfolio company, Aspire Pharma on the deal. Aspire Pharma announced the acquisition of Morningside Pharmaceuticals. Morningside Pharmaceuticals is a...
XXXLutz’s Takeover Bid for Home24
Kirkland & Ellis advised XXXLutz Group on the transaction. XXXLutz Group announced a voluntary public cash takeover offer for all outstanding shares of home24 SE. Completion...
Crescent Capital BDC’s Acquisition of First Eagle Alternative Capital BDC
Simpson Thacher advised First Eagle Alternative Capital BDC on the deal, while Kirkland & Ellis advised Crescent Capital BDC. First Eagle Alternative Capital BDC, Inc., a...
Fort Point Capital’s $340 Million Fundraising
Kirkland & Ellis advised Fort Point Capital on the deal. Fort Point Capital announced the closing of its third private equity investment fund, “FPC Small Cap...